Accreditation/
Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Acknowledgment of Commercial Support
This activity is supported by an educational grant from BeyondSpring Pharmaceuticals, Inc.
Virtual Coffee Talk: Let’s Talk About Best Practices for Neutropenia Management Today, with an Eye Toward Bridging Clinical Gaps Tomorrow!
.png)
Saturday, March 6, 2021
Live, Interactive Webcast
4:00 PM – 5:00 PM EST
Overview
Chemotherapy-induced neutropenia (CIN) is a common adverse event associated with breast cancer treatment. CIN and its associated complications, including febrile neutropenia, can have serious, life-threatening effects on patients. In addition to an increased risk of infection and worsening of disease, CIN can negatively impact cancer therapy outcomes because chemotherapy dose reductions and delays are common management strategies.
This live satellite symposium will help clinicians acquire knowledge to handle CIN-associated challenges from experts in the field who will discuss guideline recommendations, prophylactic strategies, biosimilars, and novel and emerging agents to treat real-life patients with breast cancer at risk for febrile neutropenia.
Benefits of Attending
- Learn the latest about new and emerging treatment options for patients with breast cancer undergoing chemotherapy treatment.
- Hear expert perspectives on the clinical application of recent data.
- Gain insight into how experts treat patients with breast cancer who develop neutropenia through real-life case studies.
- Submit questions and cases for discussion with experts in the field.
Acknowledgment of Commercial Support
This activity is supported by an educational grant from BeyondSpring Pharmaceuticals, Inc.
Target Audience
This educational activity is directed toward medical oncologists who treat patients with breast cancer. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of breast cancer will be invited to participate.
Learning Objectives
Upon completion of this activity, participants should have improved their ability to:
- Determine patient-, disease-, and treatment-specific characteristics used to stratify risk level for neutropenia and febrile neutropenia development during breast cancer treatment;
- Assess the impact of CIN and adverse events associated with its management on patient outcomes and quality of life along the breast cancer care continuum;
- Evaluate recently reported evidence on emerging single-agent and combination approaches for neutropenia management among patients with cancer; and
- Integrate evolving CIN prevention and management strategies into real-world scenarios
Hot Topics
- How does neutropenia affect outcomes in breast cancer patients?
- Managing neutropenia in patients with cancer during the coronavirus disease 2019 pandemic
- Incorporating novel neutropenia-attenuating agents into breast cancer care in the future
Program Chair
Professor of Medicine (Oncology)
Associate Division Chief of Medical Oncology
Stanford, CA
Registration
Registration fees include virtual conference access and e-syllabus materials.
3 Ways to Register
- Online: Click here.
- Phone: Please call +1-(888)-949-0045 or +1-(609)-378-3701 (credit cards only).
- Fax: +1-(609)-257-0705 (credit cards only).
Physicians' Education Resource®
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.
Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.
By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.
Meeting information is accurate at the time of posting.
PER® complies with the Physician Payments Sunshine Act as part of the Affordable Care Act. Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the Act.
Register
You must be logged in to PER to register for this meeting
Or Register for PER now
*Required Fields
.jpg "PER")
